[D3-A2] Latest Approaches to Quantification and Biodistribution Evaluation of Gene Therapy Products | 17th JBF Symposium

Advanced Search

Session Details

SymposiumSymposium : Gene Therapy

[D3-A2]Latest Approaches to Quantification and Biodistribution Evaluation of Gene Therapy Products

Fri. Mar 6, 2026 1:35 PM - 2:50 PM JST
Fri. Mar 6, 2026 4:35 AM - 5:50 AM UTC

Medium Hall(2nd Floor)

Chairman:Ken-ichi Yamamoto(Shin Nippon Biomedical Laboratories, Ltd.), Tamiki Mori(Mediford Corporation)

1:35 PM - 2:00 PM JST(4:35 AM - 5:00 AM UTC)

[D3-A2-01]Quantification of Viral Vectors Using the QuantStudio Absolute Q Digital PCR System

*Hiroshi Katsumoto¹ (1. Thermo Fisher Scientific Life Technologies Japan Ltd.)

Comment()

2:00 PM - 2:25 PM JST(5:00 AM - 5:25 AM UTC)

[D3-A2-02]Analytical Measurement Methods for AAV Vector Dosing Formulation: Digital PCR vs Real-Time PCR

*Yurie Okawa¹, Seulgi Lee¹, Naoki Kaname¹, Sho Nakazono¹, Sekiko Uehara¹, Haruka Inoue¹, Akiko Suzuki¹, Yukiko Arimura¹, Asako Uchiyama¹, Yohei Hayata¹ (1. Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd.)

Comment()

2:25 PM - 2:50 PM JST(5:25 AM - 5:50 AM UTC)

[D3-A2-03]Key considerations in biodistribution evaluation of gene therapy products using adeno-associated virus vectors

*Miyu Nakayama¹ (1. Takeda Pharmaceutical Company Limited)

Comment()

Back to Category List